Charlotte's Web Holdings (CWBHF) Asset Writedowns and Impairment (2021 - 2025)
Charlotte's Web Holdings' (CWBHF) quarterly Asset Writedowns and Impairment came in at $312000.0 in Q4 2025, up 36.84% year-on-year from $228000.0 in Q4 2024, and up 402.91% on a QoQ basis from -$103000.0 in Q3 2025.
Charlotte's Web Holdings (CWBHF) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 5 years of Asset Writedowns and Impairment data on file, last reported at $312000.0 in Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 36.84% year-over-year to $312000.0 in Q4 2025; TTM through Dec 2025 was $437000.0, a 850.0% increase from a year earlier, with the FY2025 full-year figure at $205000.0, down 95.06% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $312000.0, up from -$103000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for CWBHF reached as high as $98.0 million in Q4 2021 and fell as low as -$182000.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $10.3 million across 5 years, with a median of $319000.0 in 2023.
- Across the five-year window, Asset Writedowns and Impairment surged 245.17% in 2022 and plunged 100.89% in 2023, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $98.0 million in 2021, then plunged by 79.24% to $20.3 million in 2022, then tumbled by 100.89% to -$182000.0 in 2023, then soared by 225.27% to $228000.0 in 2024, then soared by 36.84% to $312000.0 in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $312000.0 in Q4 2025, -$103000.0 in Q3 2025, and $228000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 312,000.00 |
| Dec 31, 2025 | 312,000.00 |
| Sep 30, 2025 | -103,000.00 |
| Sep 30, 2025 | -103,000.00 |
| Dec 31, 2024 | 228,000.00 |
| Dec 31, 2024 | 228,000.00 |
| Dec 31, 2023 | -182,000.00 |
| Dec 31, 2023 | -182,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 326,000.00 |
| Mar 31, 2023 | 326,000.00 |
| Dec 31, 2022 | 20.35 Mn |
| Dec 31, 2022 | 20.35 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Dec 31, 2021 | 98.00 Mn |
| Dec 31, 2021 | 98.00 Mn |